|
|
News Breaks | | | | March 19, 2013 | | 08:38 EDT |  | AFFY | Affymax price target lowered to 50c from $2.50 at JMP Securities
JMP Securities reduced its price target on Affymax after the company said it was reviewing strategic options, including a wind-down of operations or bankruptcy, following the withdrawal of its anemia treatment, Omontys. The firm obtained its price target by subtracting the company's liabilities from its cash on hand, and it maintains an Underperform rating on the shares. | |
|
News For AFFY From The Last 14 Days Check below for free stories on AFFY the last two weeks. |
|
|
| May 14, 2013 | | 18:15 EDT |  | AFFY | Affymax CEO to step down
 Subscribe for More Information | | | 07:18 EDT |  | AFFY | BofA/Merrill to host a conference
2013 Health Care Conference is being held in Las Vegas on May 14-16. | | | May 9, 2013 | | 18:52 EDT | | AFFY | On The Fly: After Hours Movers
UP AFTER EARNINGS: Ubiquiti Networks (UBNT), up 11.6%... Unilife (UNIS), up 10.8%... Sequenom (SQNM), up 9.8%. DOWN AFTER EARNINGS: priceline.com (PCLN), down 3.2%... Allscripts (MDRX), down 6.1%... Air Lease (AL), down 10%. ALSO LOWER: Affymax (AFFY), down 11% after disclosing in a regulatory filing that its financial position may prevent it from continuing operations... Discovery Labs (DSCO), down 8.5% after filing to sell common stock... magicJack (CALL), down 6.4% after naming a new CFO. | | | 17:32 EDT | | AFFY | Affymax says may be unable to continue operations
Subscribe for More Information | | | 11:11 EDT |  | AFFY | High option volume stocks: DANG DLR CRL MWE AFFY
Subscribe for More Information | |
|
|
|
|
|
|
